Sources and Composition
Lion's Mane is a mushroom that grows on old or dead broadleaf trees, and is consumed in Japan and China without reported harmful effects.
Some common names for this mushroom also include Monkey's Head, Yamabushitake, and Satyr’s Beard and is sometimes called Houtou as that is the name of a sports drink which contained Hericium erinaceus (11th Asia Sport Festival in China of 1990).
The mushroom Lion's Mane (Hericium erinaceus) contains:
- Hericenones A and C-H
- Erinacines A-K
- Orcinol derivatives (Mycelium)
- Sialic-acid binding lectin
- Sterols, such as ergosterol and beta-sitosterol.
And a polysacchaide component (Hericium erinaceus )
- Polysaccharides, named HEF-P and belonging to the beta-glucan family; which can be broken down into four polysaccharides The percentage of polysaccharides in the fruiting bodies seems to be around 20%, with 18.59% found with an ethanol extraction with the overall structure of these polysaccharides comprising xylose (7.8%), ribose (2.7%), glucose (68.4%), arabinose (11.3%), galactose (2.5%) and mannose (5.2%).
Like most medicinal mushrooms, Lion's Mane appears to have bioactive polysaccharides (carbohydrates) in addition to some ethanolic soluble molecules
The total phenolic content of Lion's Mane appears to be in the range of 10.20+/-2.25mg gallic acid equivalents (GAE) per gram (about 1%) with the hot water extract, which appears to be up to 5-fold higher than oven cooked levels and either methanolic or freeze-dried fruit bodies. This 10.20+/-2.25mg GAE/g (phenolic content) is significantly less than the reference drug of Quercetin (194.24+/-7.58) and on a potency basis the overall antioxidant potential of lion's mane is about 17.7% that of quercetin in vitro.
The polysaccharides themselve are also active in vivo, with 300mg/kg of the polysaccharides daily for 15 days can reduce the oxidative changes induced by ischemia/reperfusion.
The phenolic antioxidant potential of Lion's Mane is significantly less than the reference drugs of Quercetin and gallic acid, although the polysaccharide content does also appear to be bioactive
Interactions with Neurology
Lion's Mane has been noted to increase mRNA expression of nerve-growth factor (NGF) in isolated astrocytes to around 5-fold that of control at 100-150ug/mL of the ethanolic extract in a concentration dependent manner, with no efficacy noted in the water extract. When testing hericenones C-E, none were found effective in the range of 10-100ug/mL and inhibiting JNK signalling appears to prevent lion's mane from acting (with p38 MAPK, PKA, PKC, and MEK not being involved).
An increase in NGF mRNA has been detected in the hippocampus, but not cortex, of mice given 5% of the diet as lion's mane for a period of seven days to around 1.3-fold of control.
Lion's Mane ethanolic extract appears to increase NGF mRNA levels, and this has been confirmed following oral administration to mice
Secretion of NGF from astrocytes has been noted to be increased with 150ug/mL of the ethanolic extract but not 50-100ug/mL while isolated erinacines (A-C) are known to stimulate NGF secretion at 1mM concentrations, with a potency greatly exceeding that of adrenaline at the same concentrations.
Seceretion of NGF from astrocytes has been noted to be increased with incubation of lion's mane ethanolic extract
When looking at neurons specifically, lion's mane appears to promote neuronal prolongation and formation of myelin
Neuronal excitability from glutamic acid appears to be attenuated in the presence of lion's mane extracts,
An analogue of the Hericenones, called 3-hydroxyhericenone, has been implicated in preserving neurons from death induced by endoplasmic reticulum stress. This mechanism of action is also seen with various benzene compounds in lion's mane.
It has also been shown, in vitro, to enhance myelination (production of myelin sheath) of neurons, which may be downstream of NGF.
Lion's Mane appears to protect rats against cognitive decline caused by β-amyloid pigmentation at the same 5% of the diet seen previously.
One human study using 3g of 98% lion's mane powder (in capsule form) showed significantly improvements on a rating scale of dementia in persons suffering from general cognitive decline. The supplement increased cognition relative to control, and the degree of improvement increased with time; however, 4 weeks after cessation saw the start of a decline back to normal despite still being significantly elevated above control.
Anxiety and Depressive symptoms have also been reduced in humans fed 2g of lion's mane, via cookies, over the course of 4 weeks. There was a significant difference between groups on the measurements of concentration and irritability, favoring the lion's mane group.
In one study conducted in rats, lion's mane water extract was able to promote neuronal regrowth after crushing injury. Rats that had a gluteal nerve damaged (purposefully) during surgery were able to walk better after ingestion of water containing the extract of the fruits. Two doses used in this study were 10 or 20mL per kg bodyweight daily, but the exact mg or mmol dose was not recorded; the two doses, however, did not differ between each other. This was conducted as a follow-up to an in vitro study suggesting neuronal growth from lion's mane, which showed no toxic symptoms.
Hericenone B has been shown to exert anti-platelet actions by inhibiting signalling from collagen through α2/β1 to release arachidonic acid (one of the two receptors that mediates thrombosis via collagen); the mechanism appears to be potent but specific in tested rabbits, with complete inhibition at 30μM (similar to 5μM aspirin as reference drug) and near complete at 10μM. Interestingly, hericenones C-E failed to have any influence on collagen-induced platelet aggregation, and while hericenone B was active on other forms of aggregation (adrenaline and U46619 but not ADP nor thrombin) it was less effective.
Hericenone B appears to potently and specifically inhibit collagen-induced platelet aggregation, with other hericenones not having much of an effect and other forms of aggregation not being significantly affected. The concentration this occurs at suggests that it is biologically relevant
Lion's Mane appears to be an ACE inhibitor (hot water extract of the fruiting bodies) with an IC50 value of 580+/-23µg/mL, significantly less than the most potent tested mushroom Ganoderma lucidum (50µg/mL).
Hot water extracts of mushrooms tends to be more potent ACE inhibitors than ethanolic or methanolic extracts, and mushroom bioactives that have been noted to inhibit ACE include D-mannose (IC50 of 3mg/mL) and L-pipecolic acid (IC50 of 23.7mg/mL). As these molecules themselves are weaker than Lion's Mane, it is currently thought that bioactives peptides underlie the ACE inhibitor potential as they have been detected in mushrooms before (Val-Ile-Glu-Lys-Tyr-Pro and Gly-Glu-Pro)
Lion's mane has ACE inhibiting properties, although they appear to be pretty weak and may not be biologically relevant. The exact molecule underlying these effects is not currently known, but it may be a bioactive peptide
Lipids and Cholesterol
Both a hot water and ethanolic extract of lion's mane have been tested in hyperlipidemic mice at 2% of the diet (1.896-3.16g/kg hot water and 2.016-3.36g/kg ethanolic) is able to reduce triglycerides (8% hot water and 27.1% ethanolic relative to control) without any apparent effect on HDL-C nor total cholesterol. These hypolipidemic effects were also observed in liver tissue (29.8% hot water and 38.8% ethanolic) and was thought to be related to the ability of the ethanolic extract to act as a PPARα agonist with an EC50 value of 40µg/mL; there was an increase in genes downstream of PPARα but no changes in PPARα expression.
Lion's Mane may act as a PPARα agonist and reduce triglycerides without any apparent effect on cholesterol
Although both the hot water and ethanolic extracts have been found inactive on cholesterol and HDL-C, an extract derived from the mycelium of lion's mane (ethanolic extract which was then lyophilized) appeared to reduce LDL by 45.5% and improve HDL-C by 31.1% when taken at an oral dose of 200mg/kg with 50mg/kg also being somewhat active.
Although the fruiting body of the mushroom (edible portion) does not appear to significantly influence lipoprotein and cholesterol metabolism, the mycelium may reduce cholesterol
Fat Mass and Obesity
Supplementation of both the hot water and ethanolic extracts of lion's mane to mice (1.896-3.16g/kg hot water and 2.016-3.36g/kg ethanolic) has been found to increase the expression of several genes involved in fat metabolism including Acad1, Srebf1, and Slc27a1, which were thought to be due to activating PPARα.
Lion's Mane appears to be a PPARα agonist, which may contribute to fat burning properties
Supplementation of lion's mane (1.896-3.16g/kg hot water extract or 2.016-3.36g/kg of the ethanolic extract) to mice is able to attenuate weight gain during a high fat diet by 30% (hot water) and 42.4% (ethanolic) associated with less fat accumulation in the liver and mesenteric adipose tissue.
The mycelium extract at 50-200mg/kg in rats, despite having cholesterol reducing properties, has failed to significantly influence body weight over the course of four weeks.
Inflammation and Immunology
Lion's Mane has been noted to suppress LPS-induced macrophage activation (mostly chloroform fraction, but also seen with water and alcoholic extracts) associated with less activation of c-Jun N-terminal kinase and less nuclear translocation of NF-kB.
The polysaccharide known as HEF-AP Fr II (a beta-glucan), conversely, has been found to stimulate macrophage activity itself as assessed by TNF-α and IL-β release at a concentration of 1mg/mL. This may be related to the increase in macrophage and T-cell count seen with incubations of this mushroom.
Differing compounds in Lion's Mane appear to differently modulate the immune system, with the polysaccharides appearing to be immunostimulatory but other molecules (mostly in the chloroform extract) appearing to suppress macrophage activation
A study in topically wounded rats with the water extract of lion's mane has noted that immune cell accumulation in the wound was reduced in the lion's mane group relative to control.
Some suppression of chemotaxis may occur in wounds
Interactions with Cancer Metabolism
In vitro, the hot water and ethanolic extracts of lion's mane show anti-metastatic potential in CT-26 colon cancer cells at 500µg/mL associated with less ERK and JNK phosphorylation which resulted in less MMP secretion and lamellipodia formation.
Both the hot water and ethanolic extracts of lion's mane appear to inhibit metastasis of colon cancer cells to the lung by 66-69% with 10mg/kg injections of extracts made of the fruiting bodies.
Interactions with Aesthetics
Safety and Toxicity
Toxicology studies in rats suggest that doses up to 5g/kg bodyweight are safe in rats when given as MUNOPHIL, which is a combination of lion's mane and Panax Ginseng. The percentage of this compound by weight that is lion's mane was not listed.
There has been one case study of a 63 year old man who suffered acute respiratory failure, and the excess lymphocytes in his lungs showed high reactivity to lion's mane daily for 4 months in dosages commonly bought. The connection between the two, when rated, is seen as a 'probably' connection.